TRENDING

TECHNOLOGY NEWS FROM AROUND THE WORLD

→
Nature MedicineNEWS
Nature MedicineNEWS

Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer

Nature Medicine, Published online: 11 November 2026; doi:10.1038/s41591-026-04716-9 This work developed and validated a computational pathology biomarker—the TROP2 normalized membrane ratio—that…

Published: Nov 11, 2026·Nature Medicine
Read at original source ↗
0 reads

Comments

No comments yet. Be the first to contribute.

✎ Write a comment